Commentary Patient-derived xenografts: a promising resource for preclinical cancer research. Karamboulas C, Ailles L. Mol Cell Oncol. 2019 Jan 8;6(1):1558684. doi: 10.1080/23723556.2018.1558684. eCollection 2019.PMID: 30788424